Related Experiment Video
Updated: Jan 15, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Double-layer hollow Cu2-x/CeO2 nanozyme enhances reactive oxygen species generation via electron transfer for
Lili Meng1, Jie Zhang1, Lingxue Tang2
1School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China.
Abstract:
Chemodynamic therapy (CDT) faces critical challenges including low reactive oxygen species (ROS) generation efficiency, short-lived oxidative stress, antioxidative tumor microenvironment (TME), and other limiting factors. Although nanozymes demonstrate remarkable ROS-generating capacity, the influence of electron transfer mechanisms on nanozyme activity remains rarely reported. Herein, a double-layer hollow nanozyme Cu2-x/CeO2@ICG (CCI) with multiple catalytic activities was designed to enhance the electron transfer between Cu and CeO₂ through its unique structure, activating peroxidase (POD), oxidase (OXD), and catalase (CAT) enzyme-like activities for TME-responsive cascade catalysis. Further density functional theory (DFT) calculations reconfirm the outstanding catalytic activity. Experiments demonstrate that the CCI nanozyme significantly enhances the tumor therapeutic efficacy through the following mechanisms: (1) the distinctive double-layer hollow architecture with a higher volume specific surface area substantially enhances electron transfer, (2) the nanozyme, possessing POD- and OXD-like enzymatic activities, efficiently converts H2O2/O2 into ·OH/·O₂-, respectively. Meanwhile, the CAT-like activity alleviates tumor hypoxia, thereby enhancing both photodynamic therapy (PDT) efficacy and OXD-like activity, (3) Cu2+/Ce4+-mediated glutathione (GSH) depletion disrupts the ROS-antioxidant balance, and ROS levels in TME are further elevated, (4) the combination of photothermal therapy (PTT)/PDT and CDT achieves sustained ROS accumulation. This study provides a novel nanozyme catalytic strategy to overcome the limitations of traditional CDT, demonstrating the clinical potential of multimodal cascade therapy.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...

